MedPath

Alimentiv Inc.

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants with Permanent Ileostomy

Not yet recruiting
Conditions
Crohns Disease
First Posted Date
2024-11-01
Last Posted Date
2024-11-04
Lead Sponsor
Alimentiv Inc.
Target Recruit Count
50
Registration Number
NCT06670638

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Phase 4
Recruiting
Conditions
Crohn Disease
Moderately to Severely Active Crohn's Disease
Disease Crohn
Interventions
First Posted Date
2024-02-14
Last Posted Date
2025-02-21
Lead Sponsor
Alimentiv Inc.
Target Recruit Count
304
Registration Number
NCT06257706
Locations
🇵🇱

GASTROMED - Kopon, Zmudzinski I Wspolnicy Sp.j., Torun, Kuyavian-Pomeranian, Poland

🇵🇱

Melita Medical Sp Zoo, Wroclaw, Lower Silesian, Poland

🇵🇱

WIP Warsaw IBD Point Profesor Kierkus, Warsaw, Masovia, Poland

and more 70 locations

VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

Recruiting
Conditions
Crohn's Disease
Interventions
First Posted Date
2024-02-08
Last Posted Date
2025-02-04
Lead Sponsor
Alimentiv Inc.
Target Recruit Count
300
Registration Number
NCT06249555
Locations
🇺🇸

GI Alliance - Sun City, Sun City, Arizona, United States

🇺🇸

Digestive and Liver Center of Florida, Kissimmee, Florida, United States

🇺🇸

Northwestern University, Evanston, Illinois, United States

and more 17 locations

Assessment of Patients With Acute Pouchitis Treated With Antibiotics

Suspended
Conditions
Pouchitis
Ulcerative Colitis
Interventions
Other: Observational, No intervention
First Posted Date
2022-02-23
Last Posted Date
2024-02-20
Lead Sponsor
Alimentiv Inc.
Target Recruit Count
43
Registration Number
NCT05252273
Locations
🇺🇸

Cleveland Clinic, Cleveland, Ohio, United States

🇳🇱

Academic Medical Center Amsterdam., Amsterdam, Netherlands

🇨🇦

Toronto Immune and Digestive Health Institute (TIDHI)., Toronto, Ontario, Canada

and more 1 locations

Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis

Terminated
Conditions
Ulcerative Colitis
Interventions
Drug: Janus Kinase Inhibitor
First Posted Date
2020-10-05
Last Posted Date
2022-01-04
Lead Sponsor
Alimentiv Inc.
Target Recruit Count
3
Registration Number
NCT04576000
Locations
🇳🇱

Amsterdam Medical Center, IBD Center, Amsterdam, North Halland, Netherlands

Determination of the Optimal Treatment Target in Ulcerative Colitis

Phase 4
Active, not recruiting
Conditions
Colitis, Ulcerative
Interventions
Biological: Treatment Algorithm A
Biological: Treatment Algorithm B
Biological: Treatment Algorithm C
First Posted Date
2020-02-06
Last Posted Date
2025-02-24
Lead Sponsor
Alimentiv Inc.
Target Recruit Count
672
Registration Number
NCT04259138
Locations
🇨🇦

LHSC - Victoria Hospital, London, Ontario, Canada

🇵🇱

Sonomed Sp. z o.o. - Centrum Medyczne, Szczecin, West Pomeranian, Poland

🇺🇦

Ternopil City Communal Emergency Medical Care Hosp, Ternopil, Ukraine

and more 55 locations

Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis

Active, not recruiting
Conditions
Ulcerative Colitis
Interventions
First Posted Date
2018-12-05
Last Posted Date
2025-05-16
Lead Sponsor
Alimentiv Inc.
Target Recruit Count
18
Registration Number
NCT03765450
Locations
🇺🇸

UCSD, San Diego, California, United States

🇺🇸

Cornell University, New York, New York, United States

🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

Phase 4
Active, not recruiting
Conditions
Crohn Disease
Remission
Interventions
Other: 5-ASA Withdrawal
First Posted Date
2017-08-24
Last Posted Date
2025-05-20
Lead Sponsor
Alimentiv Inc.
Target Recruit Count
334
Registration Number
NCT03261206
Locations
🇨🇦

University of Calgary, Calgary, Alberta, Canada

🇨🇦

University of Alberta, Edmonton, Alberta, Canada

🇨🇦

Dr. Jesse Siffledeen Professional Medical Corporation, Edmonton, Alberta, Canada

and more 43 locations

Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)

Phase 2
Terminated
Conditions
Ulcerative Colitis
Interventions
First Posted Date
2012-10-29
Last Posted Date
2021-06-23
Lead Sponsor
Alimentiv Inc.
Target Recruit Count
22
Registration Number
NCT01716039

Enhanced Algorithm for Crohn's Treatment Incorporating Early Combination Therapy

Phase 4
Completed
Conditions
Crohn's Disease
Interventions
Other: Conventional Step-care Algorithm
Other: Enhanced Treatment Algorithm
First Posted Date
2012-10-02
Last Posted Date
2021-11-11
Lead Sponsor
Alimentiv Inc.
Target Recruit Count
1095
Registration Number
NCT01698307
Locations
🇨🇦

Oravec Medicine Professional Corporation, Oshawa, Ontario, Canada

🇺🇸

Louisiana Research Center, LLC, Shreveport, Louisiana, United States

🇺🇸

Asheville Gastroenterology Associates, PA, Asheville, North Carolina, United States

and more 19 locations
© Copyright 2025. All Rights Reserved by MedPath